What is Pylarify?
Pylarify is the brand name for a PET imaging radiotracer used to help doctors detect prostate cancer that expresses PSMA (prostate-specific membrane antigen). It is administered as an injection and then imaged with a PET/CT or PET scanner to show areas where the tracer accumulates in the body. [1]
What is Pylarify used to diagnose or stage?
Pylarify is used in the PSMA-targeted PET imaging setting for prostate cancer. Clinically, PSMA PET is commonly used to find likely sites of disease (for example, when assessing spread) based on where PSMA is present. [1]
How does Pylarify work?
Pylarify is designed to bind to PSMA on prostate cancer cells. After injection, that binding concentrates the radiotracer in PSMA-expressing tissue, which PET imaging can detect and map. [1]
How is Pylarify given and what should patients expect?
Pylarify is given by injection, followed by PET imaging (typically PET/CT). The exact scheduling and preparation steps can vary by clinic and imaging protocol. [1]
Where does Pylarify fit versus other PSMA PET options?
Pylarify belongs to the broader category of PSMA-targeted PET imaging agents. Which specific agent is used can depend on local availability, imaging protocols, and regulatory approvals in a given country. [1]
Sources
- https://www.pylarify.com/